在接受机械血栓切除术的急性缺血性中风患者中,C-反应性蛋白与淋巴细胞的比率作为预后生物标志物:一项多中心研究
Hasan Dogan1, Ozkan Ozmuk1, Zülfikar Memiş2
1Department of Neurology, Faculty of Medicine, Samsun University, Samsun 55139, Turkey.
Diagnostics (Basel, Switzerland)
|November 27, 2025
概括
在急性缺血性中风中,C-反应蛋白与淋巴细胞比率 (CLR) 可以预测急性缺血性中风机械血栓切除术后的不良结果,死亡率和出血. 这种易于测量的炎症标志物提供了宝贵的预后见解.
科学领域:
- 神经学 神经学
- 生物标志物 生物标志物
- 炎症 炎症是一种炎症.
背景情况:
- "C反应性蛋白与淋巴细胞比率 (CLR) 是一种炎症生物标志物.
- 在接受机械血栓切除术 (MT) 的急性缺血性中风 (AIS) 患者的预后效用尚未得到充分证实.
- 调查CLR在MT后预测结果中的作用至关重要.
研究的目的:
- 评估MT治疗的AIS患者入院CLR的预后价值.
- 确定CLR是否预测功能结果,死亡率和症状性内出血 (sICH).
主要方法:
- 一项多中心的回顾性研究分析了714名前部循环大血管封闭症患者,这些患者接受了MT治疗.
- 收集了临床,血管和实验室数据,包括CLR (CRP/淋巴细胞计数).
- 评估的结果包括90天修改的兰金尺度 (mRS) 和sICH;物流回归确定了预测因素.
主要成果:
- CLR独立预测了功能不良的结局 (mRS 3-6),死亡率 (mRS 6) 和SICH.
- 针对功能性结果/死亡率 (≥7.51) 和sICH (≥10.64) 确定了最佳的CLR切线.
- 较高的CLR与较高的NIHSS和较低的ASPECTS分数相关.
结论:
- 入院CLR是对AIS的不良结果,死亡率和MT后的SICH的独立预测器.
- CLR是一种可访问的生物标志物,可以补充现有的预后工具.
- 需要进行前性研究来验证这些发现.
更多相关视频
08:22Isolation and Flow Cytometric Assessment of Neuroimmune Interactions in a Mini-Stroke Murine Model
Published on: June 20, 2025
414
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
3.7K
相关概念视频
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
522
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
522
01:30Acute Coronary Syndrome III: Diagnostic Studies
200
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
200
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
769
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
769